Elevated circulating levels of CCL2 have previously been shown in a number of other neuroinflammatory disorders such as ischemic stroke[27], Alzheimer’s disease[28], and traumatic brain injury[29]. Here, CCL2 is linked to early-onset autosomal dominant Alzheimer disease.